...
首页> 外文期刊>Journal of Huazhong University of Science and Technology >Cerebral Ischemic Tolerance Induced by 3-nitropropionic Acid Is Associated with Increased Expression of Erythropoietin in Rats
【24h】

Cerebral Ischemic Tolerance Induced by 3-nitropropionic Acid Is Associated with Increased Expression of Erythropoietin in Rats

机译:3-硝基丙酸诱导的脑缺血耐受与大鼠促红细胞生成素表达的增加有关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To examine the changes in erythropoietin (Epo) protein and its mRNA expression in rat brain subjected to focal ischemia and possible mechanism of the preconditioning of mitochondria! toxin 3-nitropropionic acid (3-NPA), rats were administrated either vehicle or 3-NPA at a dose of 20 mg/kg, intraperitoneally (ip), 3 days prior to a 2-h middle cerebral artery occlusion followed by 24- h reperfusion. Infarct volumes were measured by using 2, 3, 5 triphenylte trazolinm chloride (TTC) staining, and Epo protein and its mRNA levels were assessed by immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR), respectively. Our results showed that after reperfusion, Epo was found to be expressed extensively in the rat brain. It was most apparent in the basal nuclei and hippocampus, and was, to some extent, present in cortex. Preconditioning with 3-NPA caused a reduction in infarct volume. The expression of both Epo protein and mRNA increased significantly in the different brain areas in the 3-NPA pretreated group as compared with the non-pretreated ischemia model group. These results suggested that preconditioning with low dose 3-NPA could induce ischemic tolerance and neuro-protective effects by increasing the Epo expression in the ischemic and ischemia-related areas.
机译:要检查局部缺血的大鼠脑中促红细胞生成素(Epo)的表达及其mRNA表达的变化,以及线粒体预处理的可能机制!毒素3-硝基丙酸(3-NPA),在大鼠大脑中动脉闭塞2小时前3天腹膜内(ip)给予媒介物或3-NPA,剂量为20 mg / kg。 h再灌注。通过使用2、3、5三苯三氮卓唑啉氯化物(TTC)染色测量梗塞体积,并分别通过免疫组织化学和逆转录酶聚合酶链反应(RT-PCR)评估Epo蛋白及其mRNA水平。我们的结果表明,再灌注后,发现Epo在大鼠脑中广泛表达。它在基底核和海马体中最明显,并且在一定程度上存在于皮层中。用3-NPA预处理可减少梗死面积。与未预处理的缺血模型组相比,在3-NPA预处理组中,不同脑区域中Epo蛋白和mRNA的表达均显着增加。这些结果表明,低剂量的3-NPA预处理可通过增加缺血和缺血相关区域的Epo表达来诱导缺血耐受和神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号